{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:41:03Z","timestamp":1791841263755,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS117826"],"award-info":[{"award-number":["NS117826"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS117826"],"award-info":[{"award-number":["NS117826"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01034-8","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T12:42:18Z","timestamp":1750164138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Wrist accelerometry and machine learning sensitively capture disease progression in prodromal Parkinson\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Anoopum S.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"1034_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3233\/JPD-240272","volume":"14","author":"K McFarthing","year":"2024","unstructured":"McFarthing, K. et al. Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2024 update. J. Parkinsons. Dis. 14, 899\u2013912 (2024).","journal-title":"J. Parkinsons. Dis."},{"key":"1034_CR2","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3233\/JPD-230051","volume":"13","author":"C Gonzalez-Robles","year":"2023","unstructured":"Gonzalez-Robles, C. et al. Outcome measures for disease-modifying trials in Parkinson\u2019s disease: Consensus paper by the EJS ACT-PD multi-arm multi-stage trial initiative. J. Parkinsons. Dis. 13, 1011\u20131033 (2023).","journal-title":"J. Parkinsons. Dis."},{"key":"1034_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"1034_CR4","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00415-019-09348-3","volume":"266","author":"A Regnault","year":"2019","unstructured":"Regnault, A. et al. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson\u2019s disease? Learnings from the Parkinson\u2019s progression marker initiative cohort. J. Neurol. 266, 1927\u20131936 (2019).","journal-title":"J. Neurol."},{"key":"1034_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41531-024-00721-2","volume":"10","author":"JL Adams","year":"2024","unstructured":"Adams, J. L. et al. Using a smartwatch and smartphone to assess early Parkinson\u2019s disease in the WATCH-PD study over 12 months. NPJ Parkinsons Dis. 10, 112 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1034_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15874-4","volume":"12","author":"F Lipsmeier","year":"2022","unstructured":"Lipsmeier, F. et al. Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson\u2019s disease. Sci. Rep. 12, 12081 (2022).","journal-title":"Sci. Rep."},{"key":"1034_CR7","doi-asserted-by":"publisher","first-page":"eadc9669","DOI":"10.1126\/scitranslmed.adc9669","volume":"14","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Monitoring gait at home with radio waves in Parkinson\u2019s disease: A marker of severity, progression, and medication response. Sci. Transl. Med. 14, eadc9669 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1034_CR8","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/mds.25628","volume":"28","author":"W Maetzler","year":"2013","unstructured":"Maetzler, W., Domingos, J., Srulijes, K., Ferreira, J. J. & Bloem, B. R. Quantitative wearable sensors for objective assessment of Parkinson\u2019s disease. Mov. Disord. 28, 1628\u20131637 (2013).","journal-title":"Mov. Disord."},{"key":"1034_CR9","doi-asserted-by":"publisher","unstructured":"Gupta, A. S., Luddy, A. C., Khan, N. C., Reiling, S. & Thornton, J. K. Real-life Wrist Movement Patterns Capture Motor Impairment in Individuals with Ataxia-Telangiectasia. Cerebellum https:\/\/doi.org\/10.1007\/s12311-022-01385-5 (2022).","DOI":"10.1007\/s12311-022-01385-5"},{"key":"1034_CR10","doi-asserted-by":"publisher","first-page":"fcad064","DOI":"10.1093\/braincomms\/fcad064","volume":"5","author":"NM Eklund","year":"2023","unstructured":"Eklund, N. M. et al. Real-life ankle submovements and computer mouse use reflect patient-reported function in adult ataxias. Brain Commun. 5, fcad064 (2023).","journal-title":"Brain Commun."},{"key":"1034_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40917-3","volume":"14","author":"AS Gupta","year":"2023","unstructured":"Gupta, A. S., Patel, S., Premasiri, A. & Vieira, F. At-home wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis. Nat. Commun. 14, 5080 (2023).","journal-title":"Nat. Commun."},{"key":"1034_CR12","doi-asserted-by":"publisher","unstructured":"Manohar, R. et al. At-home wearables and machine learning capture motor impairment and progression in adult ataxias. Brain https:\/\/doi.org\/10.1093\/brain\/awaf154 (2025).","DOI":"10.1093\/brain\/awaf154"},{"key":"1034_CR13","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1523\/JNEUROSCI.05-07-01688.1985","volume":"5","author":"T Flash","year":"1985","unstructured":"Flash, T. & Hogan, N. The coordination of arm movements: an experimentally confirmed mathematical model. J. Neurosci. 5, 1688\u20131703 (1985).","journal-title":"J. Neurosci."},{"key":"1034_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0014-4886(92)90038-R","volume":"118","author":"T Flash","year":"1992","unstructured":"Flash, T., Inzelberg, R., Schechtman, E. & Korczyn, A. D. Kinematic analysis of upper limb trajectories in Parkinson\u2019s disease. Exp. Neurol. 118, 215\u2013226 (1992).","journal-title":"Exp. Neurol."},{"key":"1034_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00221-008-1656-6","volume":"193","author":"N Dounskaia","year":"2009","unstructured":"Dounskaia, N., Fradet, L., Lee, G., Leis, B. C. & Adler, C. H. Submovements during pointing movements in Parkinson\u2019s disease. Exp. Brain Res. 193, 529\u2013544 (2009).","journal-title":"Exp. Brain Res."},{"key":"1034_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0160644","volume":"11","author":"J Bai","year":"2016","unstructured":"Bai, J. et al. An activity index for raw accelerometry data and its comparison with other activity metrics. PLoS One 11, 1\u201314 (2016).","journal-title":"PLoS One"},{"key":"1034_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00415-024-12789-0","volume":"272","author":"JR Mammen","year":"2025","unstructured":"Mammen, J. R. et al. Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson\u2019s. J. Neurol. 272, 114 (2025).","journal-title":"J. Neurol."},{"key":"1034_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 23, 178\u2013190 (2024).","journal-title":"Lancet Neurol."},{"key":"1034_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","unstructured":"Parkinson Progression Marker Initiative The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog. Neurobiol."},{"key":"1034_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1394-3","volume":"19","author":"BR Bloem","year":"2019","unstructured":"Bloem, B. R. et al. The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson\u2019s disease. BMC Neurol. 19, 160 (2019).","journal-title":"BMC Neurol."},{"key":"1034_CR21","doi-asserted-by":"publisher","first-page":"zsy017","DOI":"10.1093\/sleep\/zsy017","volume":"41","author":"BC Galland","year":"2018","unstructured":"Galland, B. C. et al. Establishing normal values for pediatric nighttime sleep measured by actigraphy: a systematic review and meta-analysis. Sleep 41, zsy017 (2018).","journal-title":"Sleep"},{"key":"1034_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1109\/10.554760","volume":"44","author":"CV Bouten","year":"1997","unstructured":"Bouten, C. V., Koekkoek, K. T., Verduin, M., Kodde, R. & Janssen, J. D. A triaxial accelerometer and portable data processing unit for the assessment of daily physical activity. IEEE Trans. Biomed. Eng. 44, 136\u2013147 (1997).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"1034_CR23","doi-asserted-by":"publisher","unstructured":"Khan, N. C., Pandey, V., Gajos, K. Z. & Gupta, A. S. Free-Living Motor Activity Monitoring in Ataxia-Telangiectasia. Cerebellum https:\/\/doi.org\/10.1007\/s12311-021-01306-y (2021).","DOI":"10.1007\/s12311-021-01306-y"},{"key":"1034_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc."},{"key":"1034_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout, P. E. & Fleiss, J. L. Intraclass correlations: Uses in assessing rater reliability. Psychol. Bull. 86, 420\u2013428 (1979).","journal-title":"Psychol. Bull."},{"key":"1034_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1212\/WNL.0000000000002941","volume":"87","author":"JM Shefner","year":"2016","unstructured":"Shefner, J. M. et al. Quantitative strength testing in ALS clinical trials. Neurology 87, 617\u2013624 (2016).","journal-title":"Neurology"},{"key":"1034_CR27","doi-asserted-by":"crossref","unstructured":"Ryan, T. P. Sample Size Determination and Power. (John Wiley & Sons, Hoboken, NJ, USA, 2013).","DOI":"10.1002\/9781118439241"},{"key":"1034_CR28","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/acn3.51096","volume":"7","author":"SB Rutkove","year":"2020","unstructured":"Rutkove, S. B. et al. Improved ALS clinical trials through frequent at-home self-assessment: a proof of concept study. Ann. Clin. Transl. Neurol. 7, 1148\u20131157 (2020).","journal-title":"Ann. Clin. Transl. Neurol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01034-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T12:42:19Z","timestamp":1750164139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01034-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1034"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01034-8","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For the methods for extracting and characterizing submovements from wearable sensor data, a U.S. national phase patent application (no. 18\/719,106) titled \u201cSystem and method for clinical disorder assessment\u201d, was filed on June 12, 2024. The patent applicant is the General Hospital Corporation d\/b\/a Massachusetts General Hospital and the inventor is Anoopum Gupta. ASG has received research support from Biogen and Insmed. He has served as a paid consultant for Biogen, Insmed, Servier, Verge Genomics, OM1, Everyone Medicines, Quince Therapeutics, and Trace Neuroscience. SP declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}